591 related articles for article (PubMed ID: 15369681)
1. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation.
Hata AN; Breyer RM
Pharmacol Ther; 2004 Aug; 103(2):147-66. PubMed ID: 15369681
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles of DP and CRTH2 in allergic inflammation.
Kostenis E; Ulven T
Trends Mol Med; 2006 Apr; 12(4):148-58. PubMed ID: 16545607
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
4. Prostanoid receptors in anagen human hair follicles.
Colombe L; Michelet JF; Bernard BA
Exp Dermatol; 2008 Jan; 17(1):63-72. PubMed ID: 18005048
[TBL] [Abstract][Full Text] [Related]
5. The constitutive activity of ghrelin receptors is decreased by co-expression with vasoactive prostanoid receptors when over-expressed in human embryonic kidney 293 cells.
Chow KB; Leung PK; Cheng CH; Cheung WT; Wise H
Int J Biochem Cell Biol; 2008; 40(11):2627-37. PubMed ID: 18573679
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin D(2) induces contraction via thromboxane A(2) receptor in rat liver myofibroblasts.
Maruyama T; Murata T; Ayabe S; Hori M; Ozaki H
Eur J Pharmacol; 2008 Sep; 591(1-3):237-42. PubMed ID: 18586024
[TBL] [Abstract][Full Text] [Related]
7. Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells.
Kreutzer M; Fauti T; Kaddatz K; Seifart C; Neubauer A; Schweer H; Kömhoff M; Müller-Brüsselbach S; Müller R
Oncol Rep; 2007 Aug; 18(2):497-501. PubMed ID: 17611676
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E
Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802
[TBL] [Abstract][Full Text] [Related]
9. Comparison of nociceptive behavior in prostaglandin E, F, D, prostacyclin and thromboxane receptor knockout mice.
Popp L; Häussler A; Olliges A; Nüsing R; Narumiya S; Geisslinger G; Tegeder I
Eur J Pain; 2009 Aug; 13(7):691-703. PubMed ID: 18938093
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin D2 mediates neuronal protection via the DP1 receptor.
Liang X; Wu L; Hand T; Andreasson K
J Neurochem; 2005 Feb; 92(3):477-86. PubMed ID: 15659218
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of PGD2 receptors in chronic rhinosinusitis: modulation of DP and CRTH2 by PGD2.
Yamamoto M; Okano M; Fujiwara T; Kariya S; Higaki T; Nagatsuka H; Tsujigiwa H; Yamada M; Yoshino T; Urade Y; Nishizaki K
Int Arch Allergy Immunol; 2009; 148(2):127-36. PubMed ID: 18802357
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandins in the kidney: developments since Y2K.
Nasrallah R; Clark J; Hébert RL
Clin Sci (Lond); 2007 Oct; 113(7):297-311. PubMed ID: 17760567
[TBL] [Abstract][Full Text] [Related]
13. Antagonists of the prostaglandin D2 receptor CRTH2.
Pettipher R; Hansel TT
Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia.
Takayama K; Yuhki K; Ono K; Fujino T; Hara A; Yamada T; Kuriyama S; Karibe H; Okada Y; Takahata O; Taniguchi T; Iijima T; Iwasaki H; Narumiya S; Ushikubi F
Nat Med; 2005 May; 11(5):562-6. PubMed ID: 15834430
[TBL] [Abstract][Full Text] [Related]
15. Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway.
Xue L; Barrow A; Pettipher R
J Immunol; 2009 Jun; 182(12):7580-6. PubMed ID: 19494281
[TBL] [Abstract][Full Text] [Related]
16. Expression of prostanoid receptors in human lower segment pregnant myometrium.
Leonhardt A; Glaser A; Wegmann M; Hackenberg R; Nüsing RM
Prostaglandins Leukot Essent Fatty Acids; 2003 Nov; 69(5):307-13. PubMed ID: 14580364
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandins in pathogenesis and treatment of multiple sclerosis.
Mirshafiey A; Jadidi-Niaragh F
Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):543-54. PubMed ID: 20233088
[TBL] [Abstract][Full Text] [Related]
18. Prostanoids receptors signaling in different diseases/cancers progression.
Yang Y; Tang LQ; Wei W
J Recept Signal Transduct Res; 2013; 33(1):14-27. PubMed ID: 23327583
[TBL] [Abstract][Full Text] [Related]
19. Prostanoids and prostanoid receptors in signal transduction.
Bos CL; Richel DJ; Ritsema T; Peppelenbosch MP; Versteeg HH
Int J Biochem Cell Biol; 2004 Jul; 36(7):1187-205. PubMed ID: 15109566
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of guinea pig chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2).
Liu F; Gonzalo JA; Manning S; O'Connell LE; Fedyk ER; Burke KE; Elder AM; Pulido JC; Cao W; Tayber O; Qiu Y; Ghosh S; Ocain TD; Hodge MR; Suzuki-Yagawa Y
Prostaglandins Other Lipid Mediat; 2005 May; 76(1-4):133-47. PubMed ID: 15967168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
